Stifel Financial Corp Grows Stake in 10x Genomics, Inc.

3 days ago · Stifel Financial Corp raised its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 56.2% during the third quarter, according to the company in its most recent …

2%
OFF

Stifel Financial Corp Grows Stake In 10x Genomics, Inc.

4 weeks from now

3 days ago · Stifel Financial Corp raised its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 56.2% during the third quarter, according to the company in its most recent …

etfdailynews.com

$41.01
OFF

10X Genomics (TXG) Statistics & Alternative Data 2024 - AltIndex

4 weeks from now

Dec 14, 2024 · Stifel Financial Corp Grows Stake in 10x Genomics, Inc. (NASDAQ:TXG) December 29 - ETF Daily News: Geode Capital Management LLC Has $41.01 Million Position …

altindex.com

$25.00
OFF

Stifel Nicolaus Sticks To Their Buy Rating For 10x Genomics (TXG)

4 weeks from now

Oct 10, 2024 · In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on 10x Genomics (TXG – Research Report), with a price target of $25.00.The …

businessinsider.com

19%
OFF

Stifel Maintains 10x Genomics Inc - (TXG) Buy Recommendation

4 weeks from now

Apr 24, 2023 · Fintel reports that on May 4, 2023, Stifel maintained coverage of 10x Genomics Inc - (NASDAQ:TXG) with a Buy recommendation.. Analyst Price Forecast Suggests 0.19% …

nasdaq.com

$63
OFF

Stifel Nicolaus Sticks To Its Buy Rating For 10x Genomics (TXG)

4 weeks from now

Feb 16, 2024 · Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $63.0...

businessinsider.com

$25
OFF

Stifel Slashes 10X Genomics Stock PT To $25 Amid Chemistry Switch

4 weeks from now

Jul 16, 2024 · On Tuesday, Stifel, a financial services company, adjusted its outlook on 10X Genomics (NASDAQ:TXG), a life science technology company, by reducing the price target to …

investing.com

$25
OFF

Stifel Slashes 10X Genomics Stock PT To $25 Amid Chemistry Switch

4 weeks from now

Jul 17, 2024 · As 10X Genomics (NASDAQ:TXG) navigates through a pivotal transition period, the latest insights from InvestingPro provide a snapshot of the company's financial health and …

investing.com

$25
OFF

Stifel Slashes 10X Genomics Stock PT To $25 Amid Chemistry Switch

4 weeks from now

Stifel slashes 10X Genomics stock PT to $25 amid chemistry switch

investing.com

19%
OFF

TXG - 10x Genomics, Inc. (NasdaqGS) - Share Price And News - Fintel

4 weeks from now

The share price of 10x Genomics, Inc. as of December 6, 2024 is $15.87 / share. This is a decrease of -0.19% from the prior week. The Factor Analysis chart (below right) shows a view …

fintel.io

3%
OFF

Stifel Financial Corp Grows Stock Holdings In Argenx SE

4 weeks from now

Dec 16, 2024 · Stifel Financial Corp lifted its stake in argenx SE (NASDAQ:ARGX - Free Report) by 15.3% in the third quarter, according to its most recent Form 13F filing with the Securities …

marketbeat.com

4%
OFF

Geode Capital Management LLC Boosts Stock Position In 10x …

4 weeks from now

Dec 25, 2024 · Geode Capital Management LLC grew its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 2.4% in the 3rd quarter, according to the company in its …

marketbeat.com

FAQs about Stifel Financial Corp Grows Stake in 10x Genomics, Inc. Coupon?

How many funds own 10x Genomics Inc -?

There are 553 funds or institutions reporting positions in 10x Genomics Inc -. This is an increase of 13 owner (s) or 2.41% in the last quarter. Average portfolio weight of all funds dedicated to TXG is 0.23%, an increase of 43.21%. Total shares owned by institutions increased in the last three months by 2.34% to 104,878K shares. ...

Is 10x Genomics a Bruker company?

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. ...

Should you buy 10x Genomics (Arias)?

Arias covers the Healthcare sector, focusing on stocks such as 10x Genomics, Danaher, and Exact Sciences. According to TipRanks, Arias has an average return of -8.8% and a 42.45% success rate on recommended stocks. In addition to Stifel Nicolaus, 10x Genomics also received a Buy from Morgan Stanley’s Tejas Savant in a report issued today. ...

Will the 10x Genomics injunction block ongoing research?

At the request of 10x Genomics, the injunction will not block ongoing research by researchers who installed a GeoMx instrument prior to November 18, 2023. Such customers can continue to purchase GeoMx reagents for use with existing GeoMx instruments for purposes of continuing their ongoing research. ...

Why did 10x Genomics request a carve-out for geomx users?

To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023. ...